Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids
nov. 2024
Thomas A, Kluiver, et al
Nature communications
Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation
okt. 2023
Lin, Lin, et al
Science
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
mei 2023
Irene, Paassen, et al
Oncogene
Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities
